Braidwell LP is a venture capital firm that primarily focuses on later-stage investments within the healthcare and life sciences sectors, including biotechnology, pharmaceuticals, medical devices, and diagnostics. Their strategy involves a fundamental, research-driven approach, providing flexible capital and partnership to companies aiming to advance human health.
Portfolio
4
Fund Size
$3.1B
Top Stage
Series A
Last 12 Mo
1
Team
IS
Ilan Sender
Principal – Public Equities
Stage Distribution
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Surrozen, Inc. | Series D | $175M | Mar 2025 |
| Perceive Pharma | Series A | $15M | Feb 2025 |
| Caris Life Sciences | Growth | $400M | Jan 2023 |
| Jade Biosciences | Series C | $95M | — |
Top Co-Investors
GV (Google Ventures)1 shared
Frazier Life Sciences1 shared
Versant Ventures1 shared
Deep Track Capital1 shared
Franklin Templeton1 shared
RTW Investments1 shared
The Column Group1 shared
Access Biotechnology1 shared
RA Capital Management1 shared
Vivo Capital1 shared
Samsara BioCapital1 shared
OrbiMed1 shared
Last updated: 3 March 2026